Analysts expect Q32 Bio Inc. to report revenue of 528,150.00 for Q4 26, against a range of 491,276.68 to 565,023.32. The most recent reported quarter, Q3 26, came in at -1.71 M.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 53.74 M | 0.00 | 0.00 | -1.71 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 988,732.11 | 0.00 | 565,023.32 | 0.00 | 0.00 | 45,298.59 | 7.72 M | -4.70 M | -2.13 M | -1.10 M | |||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 898,317.89 | 0.00 | 491,276.68 | 0.00 | 0.00 | 40,165.77 | 6.91 M | -5.72 M | -2.39 M | -1.31 M | |||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 943,525.00 | 0.00 | 528,150.00 | 0.00 | 0.00 | 42,732.18 | 7.31 M | -5.21 M | -2.26 M | -1.20 M |
Analysts expect Q32 Bio Inc. to report earnings per share of -0.28 for Q4 26, against a range of -0.30 to -0.26. The most recent reported quarter, Q3 26, came in at -0.26, a 22.9% beat against the -0.34 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.46 | -1.16 | -0.90 | -0.78 | -0.60 | 4.58 | -0.54 | -0.44 | -0.26 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -1.20 | -1.39 | -1.12 | -0.97 | -1.14 | -0.87 | -0.59 | -0.48 | -0.33 | -0.26 | -0.39 | -0.50 | -0.30 | 0.48 | -1.01 | -0.93 | -0.59 | |||||||||
| Low Estimate | -1.38 | -1.53 | -1.24 | -1.07 | -1.34 | -0.93 | -0.69 | -0.56 | -0.35 | -0.30 | -0.43 | -0.60 | -0.32 | 0.40 | -1.23 | -0.99 | -0.69 | |||||||||
| Consensus Estimate | -1.29 | -1.46 | -1.18 | -1.02 | -1.24 | -0.90 | -0.64 | -0.52 | -0.34 | -0.28 | -0.41 | -0.55 | -0.31 | 0.44 | -1.12 | -0.96 | -0.64 |
Pull Wall Street consensus for Q32 Bio Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=QTTB&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "QTTB", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=QTTB&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();